Dr Phil Kearney ![msd_w [Converted]](https://www.innovation.cafe/au/wp-content/uploads/sites/2/2013/06/msd2.jpg)
Phil is the technology scout for Merck Research Laboratories covering India, SE Asia and the Pacific geographies. The role is to filter and evaluate external opportunities for those which match MRL requirements.
As one of Australia’s largest prescription pharmaceutical companies, Merck Sharp & Dohme is committed to finding better ways to improve the health of Australians.
Since operations began in Australia in the 1950s, almost every Australian has been touched by a medicine made by Merck Sharp & Dohme. Since 1995 Merck Sharp & Dohme has brought more than 20 new medicines to Australians, including therapies to treat cholesterol, diabetes, osteoporosis, asthma, high blood pressure and HIV. In the next five years, Merck Sharp & Dohme anticipates bringing many more medicines to Australians, including significant advances in cancer and obesity.